Tatva Chintan Pharma Chem Limited (NSE:TATVA) — Stock Price

Rs1775.60 INR
▲ 3.30% today

Tatva Chintan Pharma Chem Limited (NSE:TATVA) is currently trading at Rs1775.60 INR, up 3.30% today. Over the past 52 weeks, shares have ranged between Rs982.10 and Rs1800.10. This page tracks Tatva Chintan Pharma Chem Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see TATVA company net worth.

Tatva Chintan Pharma Chem Limited (TATVA) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Tatva Chintan Pharma Chem Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Tatva Chintan Pharma Chem Limited Income Statement — Revenue, Profit & Earnings by Year

Tatva Chintan Pharma Chem Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rs3.83 Billion Rs3.94 Billion Rs4.24 Billion Rs4.34 Billion Rs3.00 Billion
Cost of Revenue Rs1.99 Billion Rs1.83 Billion Rs2.33 Billion Rs2.02 Billion Rs1.57 Billion
Gross Profit Rs1.84 Billion Rs2.11 Billion Rs1.91 Billion Rs2.32 Billion Rs1.43 Billion
Research & Development Rs83.94 Million Rs79.42 Million Rs60.39 Million Rs37.07 Million Rs24.01 Million
SG&A Rs316.06 Million Rs58.90 Million Rs50.67 Million Rs43.84 Million Rs22.93 Million
Total Operating Expenses Rs529.16 Million Rs642.47 Million Rs491.26 Million Rs356.65 Million Rs276.52 Million
Operating Income Rs90.58 Million Rs1.46 Billion Rs1.42 Billion Rs1.96 Billion Rs1.15 Billion
EBITDA Rs342.13 Million Rs689.34 Million Rs676.30 Million Rs1.08 Billion Rs666.37 Million
EBIT Rs65.54 Million Rs437.83 Million Rs584.69 Million Rs1.00 Billion Rs601.81 Million
Interest Expense Rs12.90 Million Rs65.32 Million Rs83.62 Million Rs46.62 Million Rs43.43 Million
Income Before Tax Rs75.79 Million Rs435.68 Million Rs445.65 Million Rs1.04 Billion Rs606.96 Million
Income Tax Expense Rs18.66 Million Rs132.14 Million Rs-9.22 Million Rs82.47 Million Rs84.34 Million
Net Income Rs57.13 Million Rs303.54 Million Rs454.87 Million Rs958.74 Million Rs522.62 Million

Tatva Chintan Pharma Chem Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Tatva Chintan Pharma Chem Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rs8.36 Billion Rs8.19 Billion Rs7.56 Billion Rs6.58 Billion Rs3.15 Billion
Total Current Assets Rs2.65 Billion Rs2.98 Billion Rs3.14 Billion Rs4.36 Billion Rs1.84 Billion
Cash & Equivalents — — — — —
Short-term Investments Rs3.27 Million Rs103.64 Million Rs138.50 Million Rs8.02 Million Rs8.43 Million
Net Receivables Rs827.64 Million Rs727.83 Million Rs879.96 Million Rs613.09 Million Rs907.43 Million
Inventory Rs1.34 Billion Rs1.53 Billion Rs1.62 Billion Rs1.70 Billion Rs720.19 Million
Property, Plant & Equipment — — — Rs2.11 Billion Rs1.30 Billion
Goodwill — — — — —
Total Liabilities Rs974.25 Million Rs816.36 Million Rs2.42 Billion Rs1.85 Billion Rs1.49 Billion
Total Current Liabilities Rs960.27 Million Rs796.63 Million Rs2.39 Billion Rs1.71 Billion Rs1.18 Billion
Long-term Debt Rs0.00 Rs6.39 Million Rs42.30 Million Rs131.11 Million Rs267.63 Million
Net Debt Rs222.92 Million Rs-210.33 Million Rs1.43 Billion Rs569.21 Million Rs857.67 Million
Total Stockholder Equity Rs7.39 Billion Rs7.37 Billion Rs5.15 Billion Rs4.73 Billion Rs1.66 Billion
Retained Earnings Rs3.09 Billion Rs3.08 Billion Rs2.83 Billion Rs2.41 Billion Rs1.46 Billion

Tatva Chintan Pharma Chem Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Tatva Chintan Pharma Chem Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rs246.71 Million Rs980.44 Million Rs277.83 Million Rs203.78 Million Rs243.19 Million
Capital Expenditures Rs762.72 Million Rs1.29 Billion Rs2.03 Billion Rs891.57 Million Rs209.70 Million
Free Cash Flow Rs-516.01 Million Rs-304.71 Million Rs-1.75 Billion Rs-687.79 Million Rs33.49 Million
Investing Cash Flow Rs-652.54 Million Rs-1.21 Billion Rs-1.01 Billion Rs-1.97 Billion Rs-210.06 Million
Financing Cash Flow Rs165.66 Million Rs305.19 Million Rs377.95 Million Rs2.35 Billion Rs-88.01 Million
Dividends Paid Rs46.78 Million Rs46.78 Million Rs44.33 Million Rs44.33 Million Rs40.18 Million
Stock-Based Compensation — — — — —
Depreciation Rs276.59 Million Rs256.05 Million Rs95.55 Million Rs81.80 Million Rs67.32 Million
Change in Cash Rs-239.30 Million Rs79.39 Million Rs-356.51 Million Rs585.36 Million Rs-54.88 Million

Tatva Chintan Pharma Chem Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Tatva Chintan Pharma Chem Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Jan 21, 2026 6.49 4.50 +44.22%
Oct 31, 2025 4.24 4.00 +6.00%
Jul 24, 2025 2.19 2.00 +9.50%
May 02, 2025 0.44 2.20 -80.00%
Jan 28, 2025 0.06 -0.20 +130.00%
Oct 25, 2024 -0.29 1.30 -122.31%
Jul 24, 2024 2.23 5.60 -60.18%
May 03, 2024 4.11 4.10 +0.24%